Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 524291, 6 pages
http://dx.doi.org/10.1155/2015/524291
Research Article

Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men

1Department of Laboratory Medicine and Molecular Genetics and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 626-770, Republic of Korea
2Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 626-770, Republic of Korea
3Department of Family Medicine, Pusan National University Hospital, Busan 49241, Republic of Korea
4Research And Statistical Support, Research Institute of Convergence for Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 626-770, Republic of Korea

Received 20 May 2015; Accepted 25 August 2015

Academic Editor: Doan T. M. Ngo

Copyright © 2015 Sun Min Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Meigs, P. W. F. Wilson, C. S. Fox et al., “Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 2906–2912, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. W. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise, and W. B. Kannel, “Overweight and obesity as determinants of cardiovascular risk: the framingham experience,” Archives of Internal Medicine, vol. 162, no. 16, p. 1867, 2002. View at Publisher · View at Google Scholar
  3. A. Hiuge-Shimizu, K. Kishida, T. Funahashi et al., “Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study),” Annals of Medicine, vol. 44, no. 1, pp. 82–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Kishida, T. Funahashi, and I. Shimomura, “Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective,” Current Diabetes Reviews, vol. 8, no. 2, pp. 84–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-W. Park, D. B. Allison, S. B. Heymsfield, and D. Gallagher, “Larger amounts of visceral adipose tissue in Asian Americans,” Obesity Research, vol. 9, no. 7, pp. 381–387, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Khoo, S. Sairazi, S. Taslim et al., “Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population,” Diabetes Care, vol. 34, no. 5, pp. 1120–1126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: A feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. J. G. Lee, S. Lee, Y. J. Kim et al., “Multiple biomarkers and their relative contributions to identifying metabolic syndrome,” Clinica Chimica Acta, vol. 408, no. 1-2, pp. 50–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Onat, H. Uyarel, G. Hergenc et al., “Serum uric acid is a determinant of metabolic syndrome in a population-based study,” American Journal of Hypertension, vol. 19, no. 10, pp. 1055–1062, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr., and P. W. F. Wilson, “C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the framingham offspring study,” Circulation, vol. 110, no. 4, pp. 380–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Sies, “Biochemistry of oxidative stress,” Angewandte Chemie—International Edition in English, vol. 25, no. 12, pp. 1058–1071, 1986. View at Publisher · View at Google Scholar
  12. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., “Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the framingham study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434–439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. O. Olusi, “Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans,” International Journal of Obesity, vol. 26, no. 9, pp. 1159–1164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-M. Fernández-Real, M. Broch, J. Vendrell, and W. Ricart, “Insulin resistance, inflammation, and serum fatty acid composition,” Diabetes Care, vol. 26, no. 5, pp. 1362–1368, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Saito, K. Yonemasu, and F. Inami, “Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan,” Circulation Journal, vol. 67, no. 4, pp. 323–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Davì, M. T. Guagnano, G. Ciabattoni et al., “Platelet activation in obese women: role of inflammation and oxidant stress,” Journal of the American Medical Association, vol. 288, no. 16, pp. 2008–2014, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Aronson and E. J. Rayfield, “How hyperglycemia promotes atherosclerosis: molecular mechanisms,” Cardiovascular Diabetology, vol. 1, article 1, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. K. Vincent, S. K. Powers, A. J. Dirks, and P. J. Scarpace, “Mechanism for obesity-induced increase in myocardial lipid peroxidation,” International Journal of Obesity, vol. 25, no. 3, pp. 378–388, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Wallström, E. Wirfält, P. H. Lahmann, B. Gullberg, L. Janzon, and G. Berglund, “Serum concentrations of β-carotene and α-tocopherol are associated with diet, smoking, and general and central adiposity,” American Journal of Clinical Nutrition, vol. 73, no. 4, pp. 777–785, 2001. View at Google Scholar · View at Scopus
  21. A. A. Horton, S. Fairhurst, and J. S. Bus, “Lipid peroxidation and mechanisms of toxicity,” Critical Reviews in Toxicology, vol. 18, no. 1, pp. 27–79, 1987. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Seljeskog, T. Hervig, and M. A. Mansoor, “A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit,” Clinical Biochemistry, vol. 39, no. 9, pp. 947–954, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Risérus, J. Ärnlöv, K. Brismar, B. Zethelius, L. Berglund, and B. Vessby, “Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men,” Diabetes Care, vol. 27, no. 8, pp. 2041–2046, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B.-K. Lee and Y. Kim, “Iron deficiency is associated with increased levels of blood cadmium in the Korean general population: analysis of 2008-2009 Korean National Health and Nutrition Examination Survey data,” Environmental Research, vol. 112, pp. 155–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Lee, H. K. Park, S. P. Son, C. W. Lee, I. J. Kim, and H. J. Kim, “Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 19, no. 11, pp. 781–788, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. L. Craig, A. L. Marshall, M. Sjöström et al., “International physical activity questionnaire: 12-country reliability and validity,” Medicine and Science in Sports and Exercise, vol. 35, no. 8, pp. 1381–1395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Mendes, C. Cardoso, and C. Pestana, “Measurement of malondialdehyde in fish: a comparison study between HPLC methods and the traditional spectrophotometric test,” Food Chemistry, vol. 112, no. 4, pp. 1038–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Lykkesfeldt, “Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 50–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Jang, O. Y. Kim, H. J. Ryu et al., “Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men,” Journal of Lipid Research, vol. 44, no. 12, pp. 2356–2364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Lemieux, A. Pascot, D. Prud'homme et al., “Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 6, pp. 961–967, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Cartier, M. Côté, I. Lemieux et al., “Age-related differences in inflammatory markers in men: contribution of visceral adiposity,” Metabolism, vol. 58, no. 10, pp. 1452–1458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Block, M. Dietrich, E. P. Norkus et al., “Factors associated with oxidative stress in human populations,” American Journal of Epidemiology, vol. 156, no. 3, pp. 274–285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Ozguner, A. Koyu, and G. Cesur, “Active smoking causes oxidative stress and decreases blood melatonin levels,” Toxicology and Industrial Health, vol. 21, no. 1-2, pp. 21–26, 2005. View at Publisher · View at Google Scholar · View at Scopus